清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

医学 接种疫苗 宫颈上皮内瘤变 疫苗效力 宫颈癌 疫苗试验 临床试验 不利影响 随机对照试验 人乳头瘤病毒疫苗 甲肝疫苗 内科学 儿科 HPV感染 妇科 病毒学 甲肝 肝炎 癌症
作者
Jaimie Z. Shing,Shangying Hu,Rolando Herrero,Allan Hildesheim,Carolina Porras,Joshua N. Sampson,John Schussler,John T. Schiller,Douglas R. Lowy,Mónica S. Sierra,Loretto Carvajal,Aimée R. Kreimer,Bernal Cortés,Paula González,Rolando Herrero,Silvia Jiménez,Carolina Porras,Ana Cecilia Rodríguez,Allan Hildesheim,Aimée R. Kreimer,Douglas R. Lowy,Mark Schiffman,John T. Schiller,Mark E. Sherman,Sholom Wacholder,Lígia A. Pinto,Troy J. Kemp,Mary K. Sidawy,Wim Quint,Leen–Jan van Doorn,Linda Struijk,Joel M. Palefsky,Teresa M. Darragh,Mark H. Stoler
出处
期刊:Lancet Oncology [Elsevier]
卷期号:23 (7): 940-949 被引量:6
标识
DOI:10.1016/s1470-2045(22)00291-1
摘要

Background In women vaccinated against human papillomavirus (HPV), reductions in cervical disease and related procedures results in more women having intact transformation zones, potentially increasing the risk of cervical lesions caused by non-vaccine-preventable HPV types, a phenomenon termed clinical unmasking. We aimed to evaluate HPV vaccine efficacy against cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and cervical intraepithelial neoplasia grade 3 or worse (CIN3+) attributed to non-preventable HPV types in the long-term follow-up phase of the Costa Rica HPV Vaccine Trial (CVT). Methods CVT was a randomised, double-blind, community-based trial done in Costa Rica. Eligible participants were women aged 18–25 years who were in general good health. Participants were randomly assigned (1:1) to receive an HPV 16 and 18 AS04-adjuvanted vaccine or control hepatitis A vaccine, using a blocked randomisation method (permuted block sizes of 14, 16, and 18). Vaccines in both groups were administered intramuscularly with 0·5 mL doses at 0, 1, and 6 months. Masking of vaccine allocation was maintained throughout the 4-year randomised trial phase, after which participants in the hepatitis A virus vaccine control group were provided the HPV vaccine and exited the study; a screening-only, unvaccinated control group was enrolled. The unvaccinated control group and HPV vaccine group were followed up for 7 years, during which treatment allocation was not masked. One of the prespecified primary endpoints for the long-term follow-up phase was precancers associated with HPV types not prevented by the vaccine, defined as histologically confirmed incident CIN2+ events or CIN3+ events attributed to any HPV type except HPV 16, 18, 31, 33, and 45. Our primary analytical period was years 7–11. Primary analyses were in all participants with at least one follow-up visit and excluded participants with a previous endpoint (ie, modified intention-to-treat cohort). Safety endpoints have been reported elsewhere. This trial is registered with ClinicalTrials.gov, NCT00128661 and NCT00867464. The randomised, masked trial phase is completed; an unmasked subset of women in the HPV-vaccinated group is under active investigation. Findings Between June 28, 2004, and Dec 21, 2005, 7466 participants were enrolled (HPV vaccine group n=3727 and hepatitis A virus vaccine control group n=3739). Between March 30, 2009, and July 5, 2012, 2836 women enrolled in the new unvaccinated control group. The primary analytical cohort (years 7 to 11) included 2767 participants in the HPV vaccine group and 2563 in the unvaccinated group for the CIN2+ events endpoint assessment and 2826 participants in the HPV vaccine group and 2592 in the unvaccinated control group for the CIN3+ events endpoint assessment. Median follow-up during years 7 to 11 for women included for the CIN2+ events analysis was 52·8 months (IQR 44·0 to 60·7) for the HPV vaccine group and 49·8 months (42·0 to 56·9) for the unvaccinated control group. During years 7 to 11, clinical unmasking was observed with a negative vaccine efficacy against CIN2+ events attributed to non-preventable HPV types (–71·2% [95% CI –164·0 to –12·5]), with 9·2 (95% CI 2·1 to 15·6) additional CIN2+ events attributed to non-preventable HPV types per 1000 HPV-vaccinated participants versus HPV-unvaccinated participants. 27·0 (95% CI 14·2 to 39·9) fewer CIN2+ events irrespective of HPV type per 1000 vaccinated participants were observed during 11 years of follow-up. Vaccine efficacy against CIN3+ events attributed to non-preventable HPV types during years 7 to 11 was –135·0% (95% CI –329·8 to –33·5), with 8·3 (3·0 to 12·8) additional CIN3+ events attributed to non-preventable HPV types per 1000 vaccinated participants versus unvaccinated participants. Interpretation Higher rates of CIN2+ events and CIN3+ events due to non-preventable HPV types in vaccinated versus unvaccinated participants suggests clinical unmasking could attenuate long-term reductions in high-grade disease following successful implementation of HPV vaccination programmes in screened populations. Importantly, the net benefit of vaccination remains considerable; therefore, HPV vaccination should still be prioritised as primary prevention for cervical cancer. Funding National Cancer Institute and National Institutes of Health Office of Research on Women's Health. Translation For the Spanish translation of the abstract see Supplementary Materials section.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
吃小孩的妖怪完成签到 ,获得积分10
3秒前
诗蕊完成签到 ,获得积分10
3秒前
WYnini完成签到 ,获得积分10
17秒前
whuhustwit完成签到,获得积分10
31秒前
zxx完成签到 ,获得积分10
38秒前
652183758完成签到 ,获得积分10
45秒前
抹缇卡完成签到 ,获得积分10
1分钟前
浩浩完成签到 ,获得积分10
1分钟前
陆黑暗完成签到 ,获得积分10
1分钟前
1分钟前
科研佟完成签到 ,获得积分10
1分钟前
cadcae完成签到,获得积分10
1分钟前
迅速的念芹完成签到 ,获得积分10
1分钟前
焚心结完成签到 ,获得积分10
1分钟前
六等于三二一完成签到 ,获得积分10
1分钟前
快乐的七宝完成签到 ,获得积分10
1分钟前
Ray完成签到 ,获得积分10
1分钟前
1分钟前
serenity完成签到 ,获得积分10
1分钟前
ChatGPT发布了新的文献求助10
2分钟前
瘦瘦煎饼完成签到 ,获得积分10
2分钟前
ChatGPT发布了新的文献求助10
2分钟前
三脸茫然完成签到 ,获得积分10
2分钟前
ChatGPT完成签到,获得积分10
2分钟前
研友完成签到 ,获得积分10
2分钟前
fffffffffffffff完成签到 ,获得积分10
2分钟前
8R60d8完成签到,获得积分0
3分钟前
lunyu完成签到 ,获得积分10
3分钟前
坚强志泽完成签到 ,获得积分10
3分钟前
俊逸的白梦完成签到 ,获得积分10
3分钟前
橘子海完成签到 ,获得积分10
3分钟前
Tianju完成签到,获得积分10
3分钟前
研友_Lmg1gZ完成签到,获得积分10
3分钟前
huazhangchina完成签到 ,获得积分10
3分钟前
高雯完成签到,获得积分10
3分钟前
芝诺的乌龟完成签到 ,获得积分0
3分钟前
张颖完成签到 ,获得积分10
4分钟前
欢呼的茗茗完成签到 ,获得积分10
4分钟前
丹妮完成签到 ,获得积分10
4分钟前
4分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052644
求助须知:如何正确求助?哪些是违规求助? 2709863
关于积分的说明 7418252
捐赠科研通 2354395
什么是DOI,文献DOI怎么找? 1246007
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921